HEPATIC IMPAIRMENT
Clinical trials for HEPATIC IMPAIRMENT explained in plain language.
Never miss a new study
Get alerted when new HEPATIC IMPAIRMENT trials appear
Sign up with your email to follow new studies for HEPATIC IMPAIRMENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Early safety check: how does a new drug behave in people with liver issues?
Knowledge-focused Not yet recruitingThis early-stage study aims to understand how a new drug called BMS-986435 is processed by the body in people with normal liver function and those with mild to moderate liver impairment. The study will enroll 24 participants to measure drug levels in the blood and monitor for saf…
Matched conditions: HEPATIC IMPAIRMENT
Phase: PHASE1 • Sponsor: Bristol-Myers Squibb • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:41 UTC
-
First human tests: how does a failing liver handle a new drug?
Knowledge-focused Not yet recruitingThis early-stage study aims to understand how a new medicine, BI 3000202, is processed by the body in people with and without liver problems. It will enroll 44 adults, including healthy volunteers and people with varying degrees of liver impairment. Each participant takes a singl…
Matched conditions: HEPATIC IMPAIRMENT
Phase: PHASE1 • Sponsor: Boehringer Ingelheim • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC